IMPROVING MEDICAL SUPPORT FOR EVENTS TO TRAIN MILITARY PERSONNEL TO PERFORM TASKS IN THE HIGHLANDS


Cite item

Full Text

Abstract

The article is dedicated to the current problems of angled towards some actual problems of etiology and diagnostics of community-acquired pneumonia, antibacterial and adjuvant treatment and the applications of scientific researches in everyday clinical practice

About the authors

A V Prokhorov

S. M. Kirov Military Medical Academy the Russian Defense Ministry, Saint Petersburg

N D Prokhorova

Вranch of the A. A. Vishnevskiy 3rd Military Hospital the Russian Defense Ministry

A A Shevelev

S. M. Kirov Military Medical Academy the Russian Defense Ministry, Saint Petersburg

References

  1. Vinogradova Y., Hippisley-Cox J., Coupland C. Identification of new risk factors for pneumonia: population-based case- control study. Br. J. Gen. Pract. 2009; 59 (567): 329-38.
  2. Aliberti S., Kaye K. S. The changing microbiologic epidemiology of community-acquired pneumonia. J. Postgrad. Med. 2013; 125 (6): 31-42.
  3. Fleming V., Buck B., Nix N., Kumar P., Southwood R. Community-acquired pneumonia with risk for drug-resistant pathogens. South. Med. J. 2013; 106 (3): 209-16.
  4. Dean N. Methicillin-resistant Staphylococcus aureus in community-acquiredandhealthcare-associatedpneumonia: incidence, diagnosis, and treatment options. Hosp. Pract. 2010; 38 (1): 7-15.
  5. Cağlayan S. D., Pullukçu H., Ciçek C., Sipahi O. R., Taşbakan S., Atalay S. Bacterial and viral etiology in hospitalized community acquired pneumonia with molecular methods and clinical evaluation. J. Infect. Dev. Ctries. 2014; 8 (4): 510-8.
  6. Viale P., Tedeschi S., Tumietto F., Ferrari R., Azzari C., Cravero R. G., Scudeller L. Prospective multicentre survey on clinical features and management approach to community- acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases. Infez. Med. 2012; 20 (4): 265-75.
  7. Curtain J. P., Sankaran P., Kamath A. V., Myint P. K. The usefulness of confusion, urea, respiratory rate, and shock index or adjusted shock index criteria in predicting combined mortality and/or ICU admission compared to CURB-65 in community-acquired pneumonia. Biomed Res. Int. 2013; 2013: 590407. Available at: http://dx.doi. org/10.1155/2013/590407 (accessed 18.05.2017).
  8. Subramanian D. N., Musonda P., Sankaran P., Tariq S. M., Kamath A. V., Myint P. K. Performance of SOAR (systolic blood pressure, oxygenation, age and respiratory rate) scoring criteria incommunity-acquired pneumonia: a prospective multi-centre study. Age Ageing. 2013; 42 (1): 94-7.
  9. Laserna E., Sibila O., Aguilar P. R., Mortensen E. M., Anzueto A., Blanquer J. M., Sanz F., Rello J., Marcos P. J., Velez M. I., Aziz N., Restrepo M. I. Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia. Chest. 2012; 142 (5): 1193-9.
  10. Lepper P. M., Ott S., Nüesch E., von Eynatten M., Schumann C., Pletz M. W., Mealing N. M., Welte T., Bauer T. T., Suttorp N., Jüni P., Bals R., Rohde G. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. Br. Med. J. 2012; 344: 3397.
  11. Albrich W. C., Dusemund F., Rüegger K., Christ-Crain M., Zimmerli W., Bregenzer T., Irani S., Buergi U., Reutlinger B., Mueller B., Schuetz P. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect. Dis. 2011; 11: 112.
  12. Schuetz P., Litke A., Albrich W. C., Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Current Opinion in Infectious Diseases. 2013; 26 (2): 159-67.
  13. Torres A., Ramirez P., Montull B., Menéndez R. Biomarkers and community-acquired pneumonia: tailoring management with biological data. Semin. Respir. Crit. Care Med. 2012; 33 (3): 266-71.
  14. Yang Y., Xu F., Shi L. Y., Diao R., Cheng Y. S., Chen X. Y., Jing J. Y., Wang X. D., Shen H. H. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China. Chin. Med. J. (Engl.). 2012; 125 (4): 639-45.
  15. Niu W. Y., Wan Y. G., Li M. Y., Wu Z. X., Zhang L. G., Wang J. X. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis. Eur. Rev. Med. Pharmacol. Sci. 2013; 17 (24): 3329-33.
  16. Chaudhry R., Sharma S., Javed S., Passi K., Dey A. B., Malhotra P. Molecular detection of Mycoplasma pneumoniae by quantitative real-time PCR in patients with community acquired pneumonia. Indian J. of Med. Res. 2013; 138: 244-51.
  17. Braun E., Kheir J., Mashiach T., Naffaa M., Azzam Z. S. Is elevated red cell distribution width a prognostic predictor in adult patients with community acquiredpneumonia? BMC Infect. Dis. 2014; 14: 129.
  18. Schuetz P., Chiappa V., Briel M., Greenwald J. L. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern. Med. 2011; 171 (15): 1322-31.
  19. Pinzone M. R., Cacopardo B., Abbo L., Nunnari G. Duration of antimicrobial therapy in community acquired pneumonia: less is more. Sci. World J. 2014. doi: 10.1155/2014/759138
  20. Julián-Jiménez A., Palomo de los Reyes M. J., Parejo Miguez R., Laín-Terés N., Cuena-Boy R., Lozano-Ancín A. Improved management of community-acquired pneumonia in the emergency department. Archivos de Bronconeumologia. 2013; 49 (6): 230-40.
  21. Restrepo M. I., Mortensen E. M., Rello J., Brody J., Anzueto A. Late admission to the ICU in patients with community- acquired pneumonia is associated with higher mortality. Chest. 2010; 137 (3): 552-7.
  22. Menéndez R., Torres A., Reyes S., Zalacain R., Capelastegui A., Aspa J., Borderías L., Martín-Villasclaras J. J., Bello S., Alfageme I., de Castro F. R., Rello J., Molinos L., Ruiz-Manzano J. Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur. Respir. J. 2012; 39 (1): 156-62.
  23. Cilli A. The yield of tigecycline in the treatment of community-acquired pneumonia. Tuberkuloz ve Toraks. 2013; 61 (2): 155-61.
  24. Ramirez J. A., Cooper A. C., Wiemken T., Gardiner D., Babinchak T. Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs levofloxacin. BMC Infectious Diseases. 2012; 12: 159.
  25. Remmelts H. H., Meijvis S. C., Biesma D. H., van Velzen- Blad H., Voorn G. P., Grutters J. C., Bos W. J., Rijkers G. T. Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia. Clinical Vaccine Immunology. 2012; 19 (9): 1532-8.
  26. Meijvis S. C., Hardeman H., Remmelts H. H., Heijligenberg R., Rijkers G. T., van Velzen-Blad H., Voorn G. P., van de Garde E. M., Endeman H., Grutters J. C., Bos W. J., Biesma D. H. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011; 377 (9782): 2023-30.
  27. Remmelts H. H., Meijvis S. C., Heijligenberg R., Rijkers G. T., Oosterheert J. J., Bos W. J., Endeman H., Grutters J. C., Hoepelman A. I., Biesma D. H. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia. J. Infect. 2012; 65 (1): 25-31.
  28. Fernández-Serrano S., Dorca J., Garcia-Vidal C., Fernández- Sabé N., Carratalà J., Fernández-Agüera A., Corominas M., Padrones S., Gudiol F., Manresa F. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit. Care. 2011; 15 (2): R96. doi: 10.1186/cc10103
  29. Yende S., Milbrandt E. B., Kellum J. A., Kong L., Delude R. L., Weissfeld L. A., Angus D. C. Understanding the potential role of statins in pneumonia and sepsis. Crit. Care Med. 2011; 39 (8): 1871-8.
  30. Chalmers J. D., Short P. M., Mandal P., Akram A. R., Hill A. T. Statins in community acquired pneumonia: Evidence from experimental and clinical studies. Respir. Med. 2010; 104 (8): 1081-91.

Copyright (c) 2017 Prokhorov A.V., Prokhorova N.D., Shevelev A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies